The vaccine against the HPV human papillomavirus virus will also become available for boys.

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

As of 1 January 2017, the disorders alpha and beta thalassaemia will be added to the neonatal blood spot (‘heel prick’) screening programme.

On 26 October 2015, heel prick screening started for all newborns on St Eustatius and Saba.

January 20th, the Olive Foundation and RIVM opened AEX trading day in Amsterdam on the occasion of the 9th European Cervical Cancer Prevention Week.

Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).

In 2014 the number of girls who were immunised against the human papilloma virus (HPV) rose. This virus can cause cervical cancer later in life.

Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).

January 19 - 25 European Cervical Cancer Prevention Week.